54.40
-0.30
(-0.55%)
At close: 1:01:59 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
117,457.00
113,482.00
99,963.00
-9,191.00
771.00
Investing Cash Flow
-90,936.00
-88,431.00
2,505.00
7,013.00
9,127.00
Financing Cash Flow
-32,437.00
-116.00
--
--
--
End Cash Position
35,091.00
139,683.00
114,748.00
12,280.00
14,458.00
Capital Expenditure
-6,820.00
-5,518.00
-2,967.00
-1,987.00
-6,768.00
Free Cash Flow
110,637.00
107,964.00
96,996.00
-11,178.00
-5,997.00
12/31/2020 - 3/21/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4131.TWO NeoCore Technology Co., Ltd.
31.35
+1.13%
1777.TWO SYN-TECH Chem. & Pharm. Co., Ltd.
92.00
-0.11%
4168.TWO GlycoNex Incorporation
23.90
-0.42%
6662.TWO BioLASCO Taiwan Co., Ltd.
34.00
+3.03%
3118.TWO Level Biotechnology Inc.
32.25
-0.31%
4192.TWO SynCore Biotechnology Co.,Ltd
34.25
+2.54%
3164.TW GenMont Biotech Incorporation
19.35
-0.51%
6461.TWO Intech Biopharm Corporation
24.50
-1.41%
4726.TWO Mycenax Biotech Inc.
39.50
-1.86%
6875.TWO Pharmosa Biopharm Inc.
52.90
0.00%